Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment
ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After ea
| Condition(s) | Chronic Inflammatory Demyelinating Polyneuropathy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily. |
| Who can participate | Inclusion Criteria: * Diagnosed with CIDP or possible CIDP based on 2021 EAN/PNS criteria2. * Treated with IVIg (≤1g/kg/3-8week) * Clinically Stable disease for 3 months (according to treating physician opinion). * No treatment withdrawal failure within 1 year * Age over 18 years Exclusion Criteria: * Significant cognitive or communication disorders * Surgery or serious traumatic injury ≤ 6 months * Non ambulant patient * Current participation to a therapeutic trial * Anti-myeline antibodies (anti-MAG) positive or nodo-paranodopathy * Other autoimmune disease that requires Corticosteroids, IVIg, Plasma Exchange treatment * Pregnancy or breastfeeding * Any other condition that, according to the investigator, could significantly interfere with patient evaluation or safety. |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Lead sponsor | Centre Hospitalier Universitaire de Liege |
| Locations | Liège, Liège, Belgium |
| Start date | 2023-08-28 |
| NCT ID | NCT06183645 |
| Official listing | https://clinicaltrials.gov/study/NCT06183645 |